Adaptive Biotechnologies Corporation ADPT
$ 5.19
-2.35%
Quarterly report 2024-Q2
added 08-01-2024
Adaptive Biotechnologies Corporation Financial Ratios 2011-2024 | ADPT
Annual Financial Ratios Adaptive Biotechnologies Corporation
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.6 | -6.1 | -9.8 | -50.8 | -31.1 | - | - | - | - | - | - | - | - |
P/S |
3.5 | 6.6 | 13.1 | 75.4 | 25.1 | - | - | - | - | - | - | - | - |
EPS |
-1.6 | -1.4 | -1.5 | -1.1 | -1.0 | -3.7 | -3.5 | - | - | - | - | - | - |
EV (Enterprise Value) |
884 M | 1.53 B | 2.21 B | 7.67 B | 2.38 B | 591 M | 587 M | - | - | - | - | - | - |
EBITDA per Share |
-1.43 | -1.27 | -1.4 | -1.11 | -1.11 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-10.9 | -49.5 | -26.5 | - | - | - | - | - | - | - | - | ||
PEG |
- | 5.25 | 0.24 | - | - | - | - | - | - | - | - | ||
P/B |
1.9 | 2.6 | 3.4 | 10.0 | 3.7 | - | - | - | - | - | - | - | - |
P/CF |
-3.8 | -6.7 | -10.5 | -49.6 | 11.0 | - | - | - | - | - | - | - | - |
ROE % |
-73.04 | -43.13 | -34.31 | -19.67 | -12.01 | - | - | - | - | - | - | - | - |
ROA % |
-34.07 | -23.37 | -22.45 | -13.10 | -7.52 | - | - | - | - | - | - | - | - |
ROCE % |
-73.62 | -43.13 | -34.59 | -20.56 | -9.40 | - | - | - | - | - | - | - | - |
Current Ratio |
1.9 | 2.2 | 2.9 | 3.0 | 7.8 | - | - | - | - | - | - | - | - |
DSO |
83.6 | 56.6 | 32.5 | 42.2 | 54.4 | - | - | - | - | - | - | - | - |
DIO |
69.8 | 106.3 | 123.4 | 187.4 | 148.6 | - | - | - | - | - | - | - | - |
DPO |
38.2 | 35.9 | 24.2 | 62.3 | 73.0 | - | - | - | - | - | - | - | - |
Operating Cycle |
153.4 | 162.8 | 155.8 | 229.5 | 203.0 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
115.3 | 127.0 | 131.6 | 167.2 | 130.0 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Adaptive Biotechnologies Corporation
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.31 | -0.33 | - | -0.35 | -0.33 | -0.4 | - | -0.32 | -0.37 | -0.44 | - | -0.4 | -0.35 | -0.29 | - | -0.27 | -0.26 | -0.25 | - | -0.11 | -1.23 | -1.45 | - | -0.66 | -1.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.29 | -0.3 | - | -0.35 | -0.29 | -0.36 | - | -0.31 | -0.37 | -0.41 | - | -0.34 | -0.35 | -0.28 | - | -0.24 | -0.27 | -0.26 | - | -0.11 | -1 | -1.45 | - | -0.48 | -0.91 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-64.22 | -57.17 | -39.59 | -48.87 | -44.25 | -42.22 | -30.66 | -39.24 | -38.54 | -36.58 | -22.26 | -27.20 | -23.56 | -19.99 | -13.68 | -16.12 | -13.62 | -11.85 | -8.40 | -5.19 | 0.46 | 8.05 | 8.05 | 8.05 | 4.84 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-29.58 | -27.93 | -20.55 | -25.67 | -23.79 | -24.84 | -19.74 | -25.37 | -18.57 | -23.99 | -14.84 | -18.13 | -15.79 | -13.37 | -9.11 | -10.63 | -8.87 | -7.59 | -5.26 | -7.75 | -8.72 | -10.76 | -6.25 | -6.25 | -3.76 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-65.50 | -57.99 | -39.65 | -48.97 | -44.19 | -42.25 | -30.84 | -39.49 | -38.82 | -35.87 | -21.51 | -26.50 | -22.84 | -20.62 | -14.61 | -17.77 | -15.95 | -13.80 | -9.49 | -5.94 | 0.77 | 8.75 | 8.71 | 8.71 | 5.16 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.7 | 1.8 | 1.9 | 2.0 | 2.1 | 2.1 | 2.2 | 2.2 | - | 2.8 | 2.9 | 2.9 | 3.0 | 3.1 | 3.0 | 3.0 | 3.0 | 3.0 | 2.7 | 2.7 | 2.7 | 2.7 | 11.1 | 11.1 | 11.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
82.0 | 87.2 | - | 75.5 | 58.3 | 86.1 | - | 25.3 | 23.5 | 47.2 | - | 36.2 | 40.2 | 35.4 | - | 34.9 | 43.7 | 49.6 | - | 44.4 | 52.2 | 63.0 | - | 25.5 | 19.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
62.6 | 70.1 | - | 90.7 | 98.9 | 83.8 | - | 53.1 | 72.5 | 139.3 | - | 118.5 | 152.7 | 143.8 | - | 212.0 | 261.2 | 197.5 | - | 147.8 | 144.3 | 154.7 | - | 133.4 | 70.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
52.0 | 50.3 | - | 32.2 | 39.5 | 35.2 | - | 12.7 | 20.6 | 32.0 | - | 46.1 | 47.9 | 38.5 | - | 48.8 | 60.1 | 65.7 | - | 72.5 | 70.9 | 57.1 | - | 30.5 | 16.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
144.6 | 157.3 | - | 166.2 | 157.2 | 169.9 | - | 78.4 | 96.0 | 186.4 | - | 154.7 | 192.9 | 179.2 | - | 246.9 | 304.9 | 247.1 | - | 192.1 | 196.6 | 217.6 | - | 159.0 | 89.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
92.6 | 107.0 | - | 134.0 | 117.8 | 134.7 | - | 65.7 | 75.5 | 154.4 | - | 108.5 | 145.1 | 140.6 | - | 198.1 | 244.8 | 181.4 | - | 119.6 | 125.7 | 160.5 | - | 128.4 | 73.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency